C-reactive protein flare-response predicts long-term efficacy to first-line anti-PD-1-based combination therapy in metastatic renal cell carcinoma.
Clinical & translational immunology
View this publicationClinical & translational immunology
View this publicationSignal transduction and targeted therapy
View this publicationJournal of clinical medicine
View this publicationDiagnostics (Basel, Switzerland)
View this publicationJournal of immunotherapy (Hagerstown, Md. : 1997)
View this publicationJournal for immunotherapy of cancer
View this publicationCancers
View this publicationPublication categories: Top publication
Nature biotechnology
View this publicationFrontiers in cell and developmental biology
View this publicationJournal for immunotherapy of cancer
View this publication